Stanimir Dobrev, MPharm, currently serves as a Medical Advisor and Medical Science Liaison in Oncology at AstraZeneca since February 2023. Previously, Stanimir held the position of Medical Information Specialist at Thermo Fisher Scientific from March 2021 to January 2023 and worked as a Regulatory & Start-Up Coordinator at IQVIA from August 2020 to March 2021. Stanimir received a Master's degree in Pharmacy from the Medical University of Sofia, graduating in 2020, and completed a diploma thesis in Pharmacognosy at the University of Graz in 2020.
This person is not in any teams
This person is not in any offices